[Drug prevention of recurring urolithiasis].
D000493:Allopurinol / Q000627:therapeutic use; D000535:Aluminum / Q000627:therapeutic use; D000643:Ammonium Chloride / Q000627:therapeutic use; D001205:Ascorbic Acid / Q000627:therapeutic use; D002951:Citrates / Q000627:therapeutic use; D005998:Glycine / Q000627:therapeutic use; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use; D010396:Penicillamine / Q000627:therapeutic use; D010710:Phosphates / Q000627:therapeutic use; D011736:Pyridoxine / Q000627:therapeutic use; D012008:Recurrence; D014545:Urinary Calculi / Q000145:classification / Q000188:drug therapy / Q000517:prevention & control*
D002951:Citrates; D010710:Phosphates; D000643:Ammonium Chloride; D000493:Allopurinol; D000535:Aluminum; D010396:Penicillamine; D008274:Magnesium; D011736:Pyridoxine; D001205:Ascorbic Acid; D005998:Glycine
Zur medikamentösen Rezidivprophylaxe der Urolithiasis.